Amgen Inc at Evercore ISI Healthcare Conference Transcript
Super excited to have Amgen management with us. I'll let you guys kick things off and we'll jump right in.
Great. Umer, thank you so much for inviting us. Again, we're always pleased to be here with you and with Evercore. At Amgen, you know our mission, our mission is to discover, develop, manufacture and deliver innovative first-in-class and/or best-in-class medicines to patients with serious illnesses all over the world. So we're glad to be here today. We continue to invest in innovation and science that enables longer, healthier lives with a strong long-term growth outlook, driven by breadth and depth across our four therapeutic areas.
We're entering the final stretch of the year. I think we can say that since it's December 3, with great momentum across the business. We delivered 10% revenue growth through the first nine months ending in September, inclusive of 11% product sales growth, and that was driven by 14% volume growth. And
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

